Urological Drug Price Stewardship: Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model

被引：14
|
作者：
Cortese, Brian D. [1 ]
Chang, Sam S. [2 ]
Talwar, Ruchika [2 ]
机构：
[1] Univ Penn Hlth Syst, Div Urol, Dept Surg, Philadelphia, PA USA
[2] Vanderbilt Univ, Dept Urol Surg, Nashville, TN USA
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷 / 02期
关键词：
Medicare Part D; health policy; drug prescriptions; drugs; generic; drug costs;
D O I：
10.1097/JU.0000000000003083
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：309 / 311
页数：3
相关论文
共 50 条
  • [31] The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis
    Fretheim, A
    Aaserud, M
    Oxman, AD
    BMC HEALTH SERVICES RESEARCH, 2003, 3 (1)
  • [32] Potential Cost Savings in Medicare Part D Across Gastroenterology: An Assessment of Alternative Drug Sourcing
    Bouvette, Christopher A.
    Bouvette, Max
    Yohannan, Bryce
    Rumman, Amir
    Ali, Ijlal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (04): : 764 - 767
  • [33] Phototherapy achieves significant cost savings by the delay of drug-based treatment in psoriasis
    Foerster, John
    Dawe, Robert
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2020, 36 (02) : 90 - 96
  • [34] Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by Therapeutic Drug Monitoring
    Fekete, S.
    Guentzel, T.
    Egberts, K.
    Geissler, J.
    Neubert, A.
    Gerlach, M.
    Romanos, M.
    Taurines, R.
    PHARMACOPSYCHIATRY, 2022, 55 (03) : 165 - 165
  • [35] Assessment of the potential impact of dose rounding parenteral chemotherapy agents on cost savings and drug waste minimization
    Chillari, Kelly A.
    Southward, Jessica
    Harrigan, Natasha
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (07) : 507 - 510
  • [36] COST SAVINGS OF WASTE ON HEALTH BY PHARMACOLOGICAL INEFFICIENCIES IN A VALUE-BASED PATIENT DRUG SAFETY PROGRAM
    Madrigal Cadavid, J.
    Tabares, J. E.
    Caro, M. A.
    Rendon, A.
    Hincapie, A. M.
    Abad, J. M.
    Molina, F.
    Estrada Acevedo, J., I
    Giraldo, P. A.
    VALUE IN HEALTH, 2022, 25 (12) : S287 - S287
  • [37] A Model-Based Analysis on Direct Costs of Adverse Drug Events and Related Cost-Savings Achievable by their Prevention in Tuscany, Italy
    Convertino, I.
    Salvadori, S.
    Pecori, A.
    Galiulo, M. T.
    Ferraro, S.
    Parrilli, M.
    Corona, T.
    Turchetti, G.
    Blandizzi, C.
    Tuccori, M.
    DRUG SAFETY, 2018, 41 (11) : 1210 - 1211
  • [38] Potential opportunity cost of neglecting to annually reassess Medicare Part D standalone prescription drug plan offerings: The price of contentment?
    Walberg, Mark P.
    Patel, Rajul A.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2009, 49 (06) : 777 - 782
  • [39] Analysis of Potential Cost-Savings After Introduction of Drug-Eluting Balloon Angioplasty for In-Stent Restenosis or Small Vessel Disease
    Park, Kyungil
    Kim, Tae-Eun
    Park, Kyung-Woo
    Kang, Hyun-Jae
    Koo, Bon-Kwon
    Kim, Hyo-Soo
    KOREAN CIRCULATION JOURNAL, 2011, 41 (12) : 705 - 711
  • [40] Cost Effectiveness Comparison of a Dry Powder Inhaler to a Metered Dose Inhaler plus Valved Holding Chamber based on an In-Vitro Drug Delivery Model
    Nagel, Mark
    Suggett, Jason
    Ellery, Alison
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
12345